Sullivan, Bruyette, Speros & Blaney’s Thermo Fisher Scientific TMO Stock Holding History

Sullivan, Bruyette, Speros & Blaney’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$1.26M	Buy	2,752 +1,330	+94%	+$635K	0.06%	98
2020 Q4	$662K	Sell	1,422 -37	-3%	-$17.3K	0.03%	138
2020 Q3	$644K	Sell	1,459 -4	-0.3%	-$1.65K	0.04%	130
2020 Q2	$530K	Buy	1,463 +195	+15%	+$65.4K	0.03%	133
2020 Q1	$360K	Hold	1,268	–	–	0.03%	149
2019 Q4	$412K	Sell	1,268 -293	-19%	-$88.8K	0.02%	158
2019 Q3	$455K	Buy	1,561 +342	+28%	+$97.9K	0.03%	141
2019 Q2	$358K	Buy	1,219 +414	+51%	+$114K	0.02%	160
2019 Q1	$220K	Buy	+805	New	+$200K	0.01%	201

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Sullivan, Bruyette, Speros & Blaney's TMO Position: Q1 2021 in Review

Sullivan, Bruyette, Speros & Blaney increased its Thermo Fisher Scientific (TMO) stake by 94% in Q1 2021, buying an estimated $635K and bringing the position to 2,752 shares worth $1.26M. The position accounts for 0.06% of the portfolio, ranked #98.

Sullivan, Bruyette, Speros & Blaney first reported a position in TMO in Q1 2019 and has held it in 9 quarters since. 2,042 funds tracked by Wall St. Rank hold TMO as of Q1 2021.

Sullivan, Bruyette, Speros & Blaney held 2,752 shares of Thermo Fisher Scientific worth $1.26M as of Q1 2021.
Sullivan, Bruyette, Speros & Blaney bought 1,330 Thermo Fisher Scientific shares in Q1 2021, an estimated $635K.
Thermo Fisher Scientific made up 0.06% of Sullivan, Bruyette, Speros & Blaney's portfolio in Q1 2021, its #98 holding.
Sullivan, Bruyette, Speros & Blaney first reported a position in Thermo Fisher Scientific in Q1 2019 and has held it in 9 quarters since.
2,042 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2021.

Based on Sullivan, Bruyette, Speros & Blaney's 13F filing for Q1 2021, filed 10 May 2021.